Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAK-875 Hemihydrate (Fasiglifam) is a selective GPR40 agonist with EC50 of 14 nM, 400-fold more potent than oleic acid.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 153,500 |
50 mg | 約6-8 週間 | ¥ 199,500 |
1 mL * 10 mM (in DMSO) | 約6-8 週間 | ¥ 74,000 |
説明 | TAK-875 Hemihydrate (Fasiglifam) is a selective GPR40 agonist with EC50 of 14 nM, 400-fold more potent than oleic acid. |
ターゲット&IC50 | FFA1/GPR40:14 nM(EC50) |
別名 | TAK-875, Fasiglifam |
分子量 | 533.63 |
分子式 | C29H32O7S·1/2H2O |
CAS No. | 1374598-80-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: <1 mg/mL
DMSO: 93 mg/mL (174.3 mM)
H2O: <1 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TAK-875 Hemihydrate 1374598-80-7 Endocrinology/Hormones GPCR/G Protein GPR TAK-875 TAK875 TAK875 Hemihydrate Fasiglifam TAK 875 Hemihydrate TAK 875 Inhibitor inhibitor inhibit